Cardiac myosin heavy chains in mice treated with NG-nitro-l-arginine methyl ester and thyroxine
Autor: | Othman El shboul, Mukhallad A. Mohammad, Mohamad Jaffer Mohamad, Muhanad S. Abdelwahab, Waleed R. Ezzat |
---|---|
Rok vydání: | 2013 |
Předmět: |
medicine.medical_specialty
Hematology Chemistry medicine.medical_treatment Intraperitoneal injection Cardiac muscle Pathology and Forensic Medicine Muscle hypertrophy medicine.anatomical_structure Endocrinology Oral administration Internal medicine Myosin medicine Distribution (pharmacology) Anatomy Polyacrylamide gel electrophoresis |
Zdroj: | Comparative Clinical Pathology. 23:1639-1644 |
ISSN: | 1618-565X 1618-5641 |
DOI: | 10.1007/s00580-013-1838-x |
Popis: | The aim of this study was to evaluate the effect of NG-nitro-l-arginine methyl ester and thyroxine on the distribution of cardiac myosin heavy chains in mice. Myocardial hypertrophy was induced in mice by intraperitoneal injection with l-thyroxine and oral administration of NG-nitro-l-arginine methyl ester (l-NAME). Mice were randomly allocated into five groups: control, high and low doses of thyroxine and L-NAME. Heart weight divided by body weight was calculated and used as indicator for cardiac hypertrophy. Myosin heavy chains (MHCs) were separated using 4 % polyacrylamide gel electrophoresis. Hypertrophy was induced in mice treated with thyroxine and a high dose of l-NAME and was accompanied by a shift toward α-MHC in thyroxine-treated mice and β-MHC in l-NAME-treated mice. There was no difference with respect to MHC between a low dose of l-NAME and a high dose; however, low doses of l-NAME did not result in cardiac hypertrophy. In conclusion, l-NAME treatment changes the MHC distribution from α- toward β-MHC and this transition in the MHCs occurs before heart hypertrophy. Further investigations are needed to determine whether l-NAME treatment causes this transition via a direct or indirect effect on the heart muscles. |
Databáze: | OpenAIRE |
Externí odkaz: |